These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 17345768
1. [Quantitative detection of DD3 mRNA in prostate cancer tissues by real-time fluorescent quantitative reverse transcription polymerase chain reaction]. Tao ZH, Mao XL, Wang CH, Chen XD, Yu KY, Weng ZL, Hu YP, Zhang XH, Xie H, Wang OC, Song QT, Li CD, Chen ZG. Zhonghua Nan Ke Xue; 2007 Feb; 13(2):130-3. PubMed ID: 17345768 [Abstract] [Full Text] [Related]
2. [Detection of urine DD3/PSA mRNA ratio by duplex TaqMan RT-PCR assay and evolution of its primary application]. Chen FP, Chen LL, Shen M, Chen W, Tao ZH, Wu XL, Hu YP, Li CD, Chen ZG, Chen XD. Zhonghua Yi Xue Za Zhi; 2008 Jan 22; 88(4):261-4. PubMed ID: 18361839 [Abstract] [Full Text] [Related]
3. Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis. Klecka J, Holubec L, Pesta M, Topolcan O, Hora M, Eret V, Finek J, Chottova-Dvorakova M, Babjuk M, Novak K, Stolz J. Anticancer Res; 2010 Feb 22; 30(2):665-70. PubMed ID: 20332487 [Abstract] [Full Text] [Related]
4. [Quantitative detection of differential display code 3 mRNA in peripheral blood of patients with prostate cancer]. Weng ZL, Yu KY, Mao XL, Tao ZH, Chen XD, Wu XL, Hu YP, Wang SQ, Li CD, Chen ZG. Zhonghua Yi Xue Za Zhi; 2006 Nov 07; 86(41):2911-5. PubMed ID: 17288789 [Abstract] [Full Text] [Related]
5. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. de Kok JB, Verhaegh GW, Roelofs RW, Hessels D, Kiemeney LA, Aalders TW, Swinkels DW, Schalken JA. Cancer Res; 2002 May 01; 62(9):2695-8. PubMed ID: 11980670 [Abstract] [Full Text] [Related]
6. DD3(PCA3) gene expression in cancer and prostatic hyperplasia. Floriano-Sánchez E, Cárdenas-Rodríguez N, Castro-Marín M, Alvarez-Grave P, Lara-Padilla E. Clin Invest Med; 2009 Dec 01; 32(6):E258. PubMed ID: 20003831 [Abstract] [Full Text] [Related]
7. [Detection of DD3 mRNA in the urine of prostate cancer patients and its clinical significance]. Liu GX, Guo HQ, Li XG, Gan WD, Zeng LQ, Shi HL, Zhang SW, Liu TS. Zhonghua Nan Ke Xue; 2007 Jun 01; 13(6):511-3. PubMed ID: 17615974 [Abstract] [Full Text] [Related]
8. Expression of human telomerase reverse transcriptase, Survivin, DD3 and PCGEM1 messenger RNA in archival prostate carcinoma tissue. Bialkowska-Hobrzanska H, Driman DK, Fletcher R, Harry V, Razvi H. Can J Urol; 2006 Feb 01; 13(1):2967-74. PubMed ID: 16515751 [Abstract] [Full Text] [Related]
9. Quantitative real-time RT-PCR of CD24 mRNA in the detection of prostate cancer. Schostak M, Krause H, Miller K, Schrader M, Weikert S, Christoph F, Kempkensteffen C, Kollermann J. BMC Urol; 2006 Mar 15; 6():7. PubMed ID: 16539730 [Abstract] [Full Text] [Related]
10. The combination of urine DD3(PCA3) mRNA and PSA mRNA as molecular markers of prostate cancer. Mearini E, Antognelli C, Del Buono C, Cochetti G, Giannantoni A, Nardelli E, Talesa VN. Biomarkers; 2009 Jun 15; 14(4):235-43. PubMed ID: 19489685 [Abstract] [Full Text] [Related]
11. [Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance]. Liu BQ, Wu YD, Wei JX, Zhang T, Liu RL, Ma TX. Zhonghua Nan Ke Xue; 2007 Nov 15; 13(11):997-1001. PubMed ID: 18077911 [Abstract] [Full Text] [Related]
12. Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer. Avgeris M, Koutalellis G, Fragoulis EG, Scorilas A. Clin Biochem; 2008 Oct 15; 41(14-15):1140-9. PubMed ID: 18586020 [Abstract] [Full Text] [Related]
13. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate. Zhigang Z, Wenlu S. Prostate; 2008 Feb 01; 68(2):190-9. PubMed ID: 18076024 [Abstract] [Full Text] [Related]
14. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia. Zhao Z, Liu J, Li S, Shen W. Prostate; 2009 Sep 01; 69(12):1292-302. PubMed ID: 19462463 [Abstract] [Full Text] [Related]
15. Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions. Schostak M, Miller K, Krause H, Schrader M, Kempkensteffen C, Kollermann J. Cancer Detect Prev; 2006 Sep 01; 30(5):449-54. PubMed ID: 17067752 [Abstract] [Full Text] [Related]
16. Reverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: potential value in molecular staging of prostate cancer. Joung JY, Yang SO, Jeong IG, Han KS, Seo HK, Chung J, Park WS, Lee KH. Int J Urol; 2007 Jul 01; 14(7):635-43. PubMed ID: 17645609 [Abstract] [Full Text] [Related]
17. Is DD3 a new prostate-specific gene? Gandini O, Luci L, Stigliano A, Lucera R, Di Silverio F, Toscano V, Cardillo MR. Anticancer Res; 2003 Jul 01; 23(1A):305-8. PubMed ID: 12680228 [Abstract] [Full Text] [Related]
18. [Expression of nucleostemin in prostate cancer tissues and its clinical significance]. Liu RL, Xu Y, Zhang ZH, Wang M, Sun JT, Qi SY, Zhang Y, Li SZ. Zhonghua Nan Ke Xue; 2008 May 01; 14(5):418-22. PubMed ID: 18572860 [Abstract] [Full Text] [Related]
19. Combined analysis of multiple mRNA markers by RT-PCR assay for prostate cancer diagnosis. Neves AF, Araújo TG, Biase WK, Meola J, Alcântara TM, Freitas DG, Goulart LR. Clin Biochem; 2008 Oct 01; 41(14-15):1191-8. PubMed ID: 18640109 [Abstract] [Full Text] [Related]
20. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia. Tilli TM, Thuler LC, Matos AR, Coutinho-Camillo CM, Soares FA, da Silva EA, Neves AF, Goulart LR, Gimba ER. Exp Mol Pathol; 2012 Feb 01; 92(1):13-9. PubMed ID: 21963599 [Abstract] [Full Text] [Related] Page: [Next] [New Search]